Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
UnitedHealth Group Corp a un objectif de cours consensuel de 567,61 $ basé sur les notes de 38 analystes. Le plus haut est de 1 350 $ émis par HSBC le 10 mai 2024<. Le plus bas est de 100 $ émis par Deutsche Bank le 5 août 2024. Les 3 dernières notations d'analystes ont été publiées par New Street Research, Goldman Sachs et Deutsche Bank respectivement le 6 août 2024, le 5 août 2024 et le 5 août 2024. Avec un objectif de cours moyen de 118,33 $ entre New Street Research, Goldman Sachs et Deutsche Bank, il existe une hausse implicite de 0,21 % pour UnitedHealth Group Corp à partir de ces notations d'analystes les plus récentes.
Sociétés d'analyse émettant des recommandations1
Piper Sandler
Jefferies
Goldman Sachs
JP Morgan
Mizuho
1calculé à partir des notes des analystes
Notes d'analystes pour UnitedHealth Group
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/29/2025 | — | Piper Sandler | $423 → $417 | Maintains | Overweight | |||
10/17/2025 | — | Jefferies | $317 → $409 | Maintains | Buy | |||
10/14/2025 | — | Goldman Sachs | → $406 | Initiates | → Buy | |||
10/09/2025 | — | JP Morgan | $310 → $425 | Maintains | Overweight | |||
10/09/2025 | — | Mizuho | $300 → $430 | Maintains | Outperform | |||
10/09/2025 | — | Barclays | $352 → $386 | Maintains | Overweight | |||
10/08/2025 | — | B of A Securities | $350 → $390 | Maintains | Neutral | |||
10/08/2025 | — | Bernstein | $379 → $433 | Maintains | Outperform | |||
10/08/2025 | — | Keybanc | $350 → $400 | Maintains | Overweight | |||
10/07/2025 | — | Wells Fargo | $267 → $400 | Maintains | Overweight | |||
09/12/2025 | — | Morgan Stanley | $325 → $395 | Maintains | Overweight | |||
09/09/2025 | — | Truist Securities | $310 → $365 | Maintains | Buy | |||
09/05/2025 | — | Bernstein | $337 → $379 | Maintains | Outperform | |||
09/04/2025 | — | Barclays | $337 → $352 | Maintains | Overweight | |||
08/26/2025 | — | Cantor Fitzgerald | $440 → $440 | Reiterates | Overweight → Overweight | |||
08/20/2025 | — | Morgan Stanley | $342 → $325 | Maintains | Overweight | |||
08/18/2025 | — | B of A Securities | $290 → $325 | Maintains | Neutral | |||
08/07/2025 | — | Mizuho | $350 → $300 | Maintains | Outperform | |||
08/06/2025 | — | JP Morgan | $418 → $310 | Maintains | Overweight | |||
08/04/2025 | — | Wells Fargo | $306 → $267 | Maintains | Overweight | |||
07/31/2025 | — | Baird | $312 → $198 | Downgrade | Neutral → Underperform | |||
07/30/2025 | — | RBC Capital | $355 → $286 | Maintains | Outperform | |||
07/30/2025 | — | Oppenheimer | $400 → $325 | Maintains | Outperform | |||
07/30/2025 | — | Keybanc | $400 → $350 | Maintains | Overweight | |||
07/30/2025 | — | Piper Sandler | $353 → $317 | Maintains | Overweight | |||
07/30/2025 | — | B of A Securities | $300 → $290 | Maintains | Neutral | |||
07/29/2025 | — | B of A Securities | $350 → $300 | Maintains | Neutral | |||
07/25/2025 | — | Wells Fargo | $351 → $306 | Maintains | Overweight | |||
07/16/2025 | — | Truist Securities | $360 → $345 | Maintains | Buy | |||
07/13/2025 | — | Morgan Stanley | $374 → $342 | Maintains | Overweight | |||
07/09/2025 | — | Barclays | $350 → $337 | Maintains | Overweight | |||
06/25/2025 | — | UBS | $400 → $385 | Maintains | Buy | |||
06/20/2025 | — | JP Morgan | $405 → $418 | Maintains | Overweight | |||
06/11/2025 | — | Baird | $356 → $312 | Downgrade | Outperform → Neutral | |||
06/03/2025 | — | Piper Sandler | $552 → $353 | Maintains | Overweight | |||
06/02/2025 | — | Barclays | $362 → $350 | Maintains | Overweight | |||
06/02/2025 | — | Keybanc | $450 → $400 | Maintains | Overweight | |||
05/21/2025 | — | HSBC | $490 → $270 | Downgrade | Hold → Reduce | |||
05/20/2025 | — | Wolfe Research | $501 → $390 | Maintains | Outperform | |||
05/19/2025 | — | TD Securities | $520 → $308 | Downgrade | Buy → Hold | |||
05/19/2025 | — | Truist Securities | $580 → $360 | Reiterates | Buy → Buy | |||
05/16/2025 | — | Mizuho | $515 → $350 | Maintains | Outperform | |||
05/16/2025 | — | RBC Capital | $525 → $355 | Maintains | Outperform | |||
05/15/2025 | — | Barclays | $513 → $362 | Maintains | Overweight | |||
05/15/2025 | — | JP Morgan | $525 → $405 | Maintains | Overweight | |||
05/14/2025 | — | Deutsche Bank | $521 → $362 | Maintains | Buy | |||
05/14/2025 | — | Oppenheimer | $600 → $400 | Maintains | Outperform | |||
05/14/2025 | — | Wells Fargo | $677 → $351 | Maintains | Overweight | |||
05/14/2025 | — | Morgan Stanley | $563 → $374 | Maintains | Overweight | |||
05/14/2025 | — | B of A Securities | $560 → $350 | Downgrade | Buy → Neutral | |||
05/14/2025 | — | Baird | $510 → $356 | Maintains | Outperform | |||
05/14/2025 | — | Keybanc | $575 → $450 | Maintains | Overweight | |||
05/13/2025 | — | Piper Sandler | $552 → $552 | Maintains | Overweight | |||
05/06/2025 | — | Mizuho | $650 → $515 | Maintains | Outperform | |||
04/29/2025 | — | Baird | $640 → $510 | Maintains | Outperform | |||
04/24/2025 | — | Barclays | $560 → $513 | Maintains | Overweight | |||
04/24/2025 | — | JP Morgan | $652 → $525 | Maintains | Overweight | |||
04/23/2025 | — | RBC Capital | $655 → $525 | Maintains | Outperform | |||
04/22/2025 | — | HSBC | $595 → $490 | Downgrade | Buy → Hold | |||
04/22/2025 | — | Morgan Stanley | $664 → $563 | Maintains | Overweight | |||
04/21/2025 | — | B of A Securities | $700 → $560 | Maintains | Buy | |||
04/21/2025 | — | Argus Research | — | Downgrade | Buy → Hold | |||
04/21/2025 | — | Truist Securities | $660 → $580 | Maintains | Buy | |||
04/21/2025 | — | Barclays | $642 → $560 | Maintains | Overweight | |||
04/21/2025 | — | Keybanc | $650 → $575 | Maintains | Overweight | |||
04/21/2025 | — | Raymond James | $635 → $540 | Reiterates | Strong Buy → Strong Buy | |||
04/21/2025 | — | Oppenheimer | $640 → $600 | Maintains | Outperform | |||
04/11/2025 | — | Truist Securities | $610 → $660 | Maintains | Buy | |||
04/09/2025 | — | Mizuho | $600 → $650 | Maintains | Outperform | |||
04/08/2025 | — | Wells Fargo | $660 → $677 | Maintains | Overweight | |||
01/28/2025 | — | Wells Fargo | $694 → $660 | Maintains | Overweight | |||
01/17/2025 | — | Barclays | $655 → $642 | Maintains | Overweight | |||
01/17/2025 | — | Keybanc | $650 → $650 | Reiterates | Overweight → Overweight | |||
01/17/2025 | — | Cantor Fitzgerald | $700 → $700 | Reiterates | Overweight → Overweight | |||
01/06/2025 | — | Truist Securities | $625 → $610 | Maintains | Buy | |||
01/02/2025 | — | Piper Sandler | $605 → $600 | Maintains | Overweight | |||
12/06/2024 | — | Oppenheimer | $610 → $640 | Maintains | Outperform | |||
12/05/2024 | — | Stephens & Co. | $605 → $675 | Maintains | Overweight | |||
12/03/2024 | — | Deutsche Bank | $595 → $625 | Maintains | Buy | |||
11/27/2024 | — | Barclays | $603 → $655 | Maintains | Overweight | |||
10/22/2024 | — | Barclays | $604 → $603 | Maintains | Overweight | |||
10/18/2024 | — | TD Cowen | $601 → $609 | Maintains | Buy | |||
10/16/2024 | — | UBS | $680 → $650 | Maintains | Buy | |||
10/16/2024 | — | Stephens & Co. | $632 → $605 | Maintains | Overweight | |||
10/16/2024 | — | Cantor Fitzgerald | $591 → $644 | Maintains | Overweight | |||
10/16/2024 | — | Truist Securities | $640 → $625 | Reiterates | Buy → Buy | |||
10/16/2024 | — | RBC Capital | $615 → $595 | Maintains | Outperform | |||
10/16/2024 | — | Keybanc | $675 → $650 | Maintains | Overweight | |||
10/16/2024 | — | Morgan Stanley | $615 → $610 | Maintains | Overweight | |||
10/16/2024 | — | B of A Securities | $675 → $650 | Maintains | Buy | |||
10/11/2024 | — | Keybanc | → $675 | Initiates | → Overweight | |||
10/01/2024 | — | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/20/2024 | — | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/16/2024 | — | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
09/10/2024 | — | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
08/19/2024 | — | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
07/23/2024 | — | Cantor Fitzgerald | $591 → $591 | Reiterates | Overweight → Overweight | |||
07/18/2024 | — | UBS | $640 → $680 | Maintains | Buy | |||
07/17/2024 | — | Argus Research | $570 → $600 | Maintains | Buy | |||
07/17/2024 | — | TD Cowen | $546 → $601 | Maintains | Buy |
FAQ
Quel est le cours indicatif de l'action UnitedHealth Group (UNH) ?
Le dernier objectif de prix pour UnitedHealth Group (NYSE:UNH) a été rapporté par Piper Sandler le octobre 29, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $417.00 s'attendant à ce que UNH se rise dans les 12 prochains mois (un possible changement de 15.61% upside). 80 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour UnitedHealth Group (UNH) ?
La dernière note d'analyste pour UnitedHealth Group (NYSE:UNH) a été fournie par Piper Sandler, et UnitedHealth Group maintenu leur note overweight.
Quand a eu lieu la dernière mise à niveau pour UnitedHealth Group (UNH) ?
Il n'y a pas de dernière amélioration pour UnitedHealth Group
Quand a eu lieu la dernière dégradation pour UnitedHealth Group (UNH) ?
La dernière réduction pour UnitedHealth Group Inc a eu lieu le juillet 31, 2025 lorsque Baird a changé leur objectif de prix de $312 à $198 pour UnitedHealth Group Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour UnitedHealth Group (UNH) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de UnitedHealth Group, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour UnitedHealth Group a été déposée le octobre 29, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 29, 2026.
La note d'analyste pour UnitedHealth Group (UNH) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de UnitedHealth Group (UNH) était un maintenu avec un objectif de prix de $423.00 à $417.00. Le prix actuel de UnitedHealth Group (UNH) est de $360.68, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.